BioCentury
ARTICLE | Company News

Viragen, Cancer Research Campaign Technology Ltd., University of Nottingham deal

July 31, 2000 7:00 AM UTC

The parties will develop a cancer vaccine to treat breast, ovarian and colorectal cancers. The vaccine will target an antigen overexpressed in tumor cells discovered at a Cancer Research Campaign labo...